Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Division_of_Signal_Transduction_Therapy> ?p ?o. }
Showing items 1 to 52 of
52
with 100 items per page.
- Division_of_Signal_Transduction_Therapy abstract "The Division of Signal Transduction Therapy or DSTT is an organization managed by the University of Dundee, the Medical Research Council, and the pharmaceutical companies AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Janssen Pharmaceutica, and Pfizer. The purpose of the collaboration is to conduct cell signalling research and to encourage development of new drug treatments for global diseases such as cancer, rheumatoid arthritis, and Parkinson’s Disease. Specifically the collaboration aims to target protein kinases and the ubiquitylation system in the development of these therapies. It is one of the largest ever collaborations between the commercial pharmaceutical industry and any academic research institute.".
- Division_of_Signal_Transduction_Therapy affiliation AstraZeneca.
- Division_of_Signal_Transduction_Therapy affiliation Boehringer_Ingelheim.
- Division_of_Signal_Transduction_Therapy affiliation GlaxoSmithKline.
- Division_of_Signal_Transduction_Therapy affiliation Janssen_Pharmaceutica.
- Division_of_Signal_Transduction_Therapy affiliation Merck_Serono.
- Division_of_Signal_Transduction_Therapy affiliation Pfizer.
- Division_of_Signal_Transduction_Therapy budget "2750000.0".
- Division_of_Signal_Transduction_Therapy formationYear "1998".
- Division_of_Signal_Transduction_Therapy numberOfStaff "200".
- Division_of_Signal_Transduction_Therapy parentOrganisation University_of_Dundee.
- Division_of_Signal_Transduction_Therapy wikiPageExternalLink dstt.
- Division_of_Signal_Transduction_Therapy wikiPageID "27817581".
- Division_of_Signal_Transduction_Therapy wikiPageRevisionID "605217552".
- Division_of_Signal_Transduction_Therapy affiliations "AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Janssen Pharmaceutica and Pfizer".
- Division_of_Signal_Transduction_Therapy budget "£2.75 million/year".
- Division_of_Signal_Transduction_Therapy formation "1998".
- Division_of_Signal_Transduction_Therapy hasPhotoCollection Division_of_Signal_Transduction_Therapy.
- Division_of_Signal_Transduction_Therapy leaderName "Dario Alessi, Philip Cohen, Ron Hay".
- Division_of_Signal_Transduction_Therapy name "Division of Signal Transduction Therapy".
- Division_of_Signal_Transduction_Therapy numStaff "200".
- Division_of_Signal_Transduction_Therapy parentOrganization University_of_Dundee.
- Division_of_Signal_Transduction_Therapy website dstt.
- Division_of_Signal_Transduction_Therapy subject Category:Biomedical_research_foundations.
- Division_of_Signal_Transduction_Therapy subject Category:Research_institutes_in_the_United_Kingdom.
- Division_of_Signal_Transduction_Therapy subject Category:University_of_Dundee.
- Division_of_Signal_Transduction_Therapy type Abstraction100002137.
- Division_of_Signal_Transduction_Therapy type Association108049401.
- Division_of_Signal_Transduction_Therapy type Group100031264.
- Division_of_Signal_Transduction_Therapy type Institute108407330.
- Division_of_Signal_Transduction_Therapy type Organization108008335.
- Division_of_Signal_Transduction_Therapy type ResearchInstitutesInTheUnitedKingdom.
- Division_of_Signal_Transduction_Therapy type SocialGroup107950920.
- Division_of_Signal_Transduction_Therapy type YagoLegalActor.
- Division_of_Signal_Transduction_Therapy type YagoLegalActorGeo.
- Division_of_Signal_Transduction_Therapy type YagoPermanentlyLocatedEntity.
- Division_of_Signal_Transduction_Therapy type Agent.
- Division_of_Signal_Transduction_Therapy type Organisation.
- Division_of_Signal_Transduction_Therapy type Organization.
- Division_of_Signal_Transduction_Therapy type Agent.
- Division_of_Signal_Transduction_Therapy type SocialPerson.
- Division_of_Signal_Transduction_Therapy type Thing.
- Division_of_Signal_Transduction_Therapy comment "The Division of Signal Transduction Therapy or DSTT is an organization managed by the University of Dundee, the Medical Research Council, and the pharmaceutical companies AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, Janssen Pharmaceutica, and Pfizer. The purpose of the collaboration is to conduct cell signalling research and to encourage development of new drug treatments for global diseases such as cancer, rheumatoid arthritis, and Parkinson’s Disease.".
- Division_of_Signal_Transduction_Therapy label "Division of Signal Transduction Therapy".
- Division_of_Signal_Transduction_Therapy sameAs m.0ch4zgh.
- Division_of_Signal_Transduction_Therapy sameAs Q5284564.
- Division_of_Signal_Transduction_Therapy sameAs Q5284564.
- Division_of_Signal_Transduction_Therapy sameAs Division_of_Signal_Transduction_Therapy.
- Division_of_Signal_Transduction_Therapy wasDerivedFrom Division_of_Signal_Transduction_Therapy?oldid=605217552.
- Division_of_Signal_Transduction_Therapy homepage dstt.
- Division_of_Signal_Transduction_Therapy isPrimaryTopicOf Division_of_Signal_Transduction_Therapy.
- Division_of_Signal_Transduction_Therapy name "Division of Signal Transduction Therapy".